Description of Parkinson's disease as a clinical syndrome

被引:677
|
作者
Fahn, S [1 ]
机构
[1] Columbia Univ Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA
关键词
Parkinson's disease; parkinsonism; Lewy body; dopamine; levodopa;
D O I
10.1111/j.1749-6632.2003.tb07458.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Parkinsonism is a clinical syndrome comprising combinations of motor problems-namely, bradykinesia, resting tremor, rigidity, flexed posture, "freezing," and loss of postural reflexes. Parkinson's disease (PD) is the major cause of parkinsonism. PD is a slowly progressive parkinsonian syndrome that begins insidiously and usually affects one side of the body before spreading to involve the other side. Pathology shows loss of neuromelanin-containing monoamine neurons, particularly dopamine (DA) neurons in the substantia nigra pars compacta. A pathologic hallmark is the presence of cytoplasmic eosinophilic inclusions (Lewy bodies) in monoamine neurons. The loss of DA content in the nigrostriatal neurons accounts for many of the motor symptoms, which can be ameliorated by DA replacement therapy-that is, levodopa. Most cases are sporadic, of unknown etiology; but rare cases of monogenic mutations (10 genes at present count) show that there are multiple causes for the neuronal degeneration. The pathogenesis of PD remains unknown. Clinical fluctuations and dyskinesias are frequent complications of levodopa therapy; these, as well as some motor features of PD, improve by resetting the abnormal brain physiology towards normal by surgical therapy. Nonmotor symptoms (depression, lack of motivation, passivity, and dementia) are common. As the disease progresses, even motor symptoms become intractable to therapy. No proven means of slowing progression have yet been found.
引用
收藏
页码:1 / 14
页数:14
相关论文
共 50 条
  • [21] Parkinson’s Disease as a Disconnection Syndrome
    Alice Cronin-Golomb
    Neuropsychology Review, 2010, 20 : 191 - 208
  • [22] Capgras syndrome in Parkinson's disease
    Mori, M.
    Hiwatani, Y.
    Hironishi, M.
    Miwa, H.
    Kondo, T.
    MOVEMENT DISORDERS, 2011, 26 : S157 - S157
  • [23] Parkinson's disease with Pisa syndrome
    Lee, KS
    Kim, JS
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S362 - S362
  • [24] Malignant syndrome in Parkinson's disease
    Linazasoro, G
    PARKINSONISM & RELATED DISORDERS, 2003, 10 (02) : 115 - 116
  • [25] Fregoli Syndrome In Parkinson's Disease
    Karaman, Yahya
    TURKISH JOURNAL OF NEUROLOGY, 2008, 14 (03) : 204 - 211
  • [26] Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment
    Barone, Paolo
    Santangelo, Gabriella
    Amboni, Marianna
    Pellecchia, Maria Teresa
    Vitale, Carmine
    LANCET NEUROLOGY, 2016, 15 (10): : 1063 - 1074
  • [27] Restless legs syndrome in Parkinson's disease Clinical characteristics and biochemical correlations
    Guerreiro, Tiago Machado
    Candido Nishikawa, Danilo Ryuko
    Ferreira, Lis Campos
    de Melo, Hyder Aragao
    Pereira do Prado, Roberto Cesar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2010, 68 (06) : 869 - 872
  • [28] Clinical features of malignant syndrome in Parkinson's disease and related neurological disorders
    Harada, T
    Mitsuoka, K
    Kumagai, R
    Murata, Y
    Kaseda, Y
    Kamei, H
    Ishizaki, F
    Nakamura, S
    PARKINSONISM & RELATED DISORDERS, 2003, 9 : S15 - S23
  • [29] Description of participant population in Parkinson's Disease Registry
    Oswald, SL
    Shill, HA
    MOVEMENT DISORDERS, 2006, 21 : S150 - S150
  • [30] Parkinson's At Risk Syndrome: Can Parkinson's Disease Be Predicted?
    Stern, Matthew B.
    Siderowf, Andrew
    MOVEMENT DISORDERS, 2010, 25 (03) : S89 - S93